Wall Street Zen upgraded shares of Movano (NASDAQ:MOVE – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Movano presently has an average rating of “Sell”.
Check Out Our Latest Analysis on MOVE
Movano Stock Up 13.6%
Insider Activity at Movano
In other news, CEO John Mastrototaro sold 33,069 shares of Movano stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total value of $687,835.20. Following the completion of the sale, the chief executive officer directly owned 56,114 shares of the company’s stock, valued at approximately $1,167,171.20. This trade represents a 37.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Michael Aaron Leabman sold 6,845 shares of the company’s stock in a transaction on Wednesday, January 14th. The shares were sold at an average price of $6.66, for a total value of $45,587.70. Following the transaction, the chief technology officer directly owned 22,639 shares in the company, valued at $150,775.74. This trade represents a 23.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 94,383 shares of company stock valued at $1,524,933 over the last quarter. Corporate insiders own 10.40% of the company’s stock.
Hedge Funds Weigh In On Movano
An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC acquired a new stake in Movano Inc. (NASDAQ:MOVE – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 16.64% of the company’s stock.
Trending Headlines about Movano
Here are the key news stories impacting Movano this week:
- Neutral Sentiment: Ad industry groups are building standards (Ad Context Protocol) for AI agents to execute media buys — a structural move that could shape digital ad spending and AI adoption but has no direct link to Movano. Ad Industry Moves to Set Rules Before AI Agents Control Media Budgets
- Neutral Sentiment: xAI plans to redeem $3B of high‑yield bonds early as corporate restructuring and IPO timing progress — relevant to broader tech/AI market sentiment but not to Movano specifically. xAI Moves to Retire $3B Debt Early as Musk Advances the Planned SpaceX IPO
- Neutral Sentiment: Electrovaya won shareholder approval for U.S. domestication and governance changes — an example of cross‑border restructuring activity in the broader health/tech supply chain universe, but not tied to Movano. Electrovaya Wins Strong Shareholder Backing for U.S. Domestication and Governance Moves
- Negative Sentiment: Escalation in U.S.–Iran tensions and related headlines are producing intermittent risk‑off moves across small caps and growth names; geopolitical jitters can sap liquidity and push volatile micro‑caps around unpredictably. Bernie Sanders Calls Iran Strikes ‘Illegal And Unconstitutional’
- Negative Sentiment: BigBear.ai reported mixed Q4 results and a soft outlook — such earnings disappointments in AI/tech names can weigh on sentiment for adjacent small‑cap tech stocks. BigBear.AI Stock Moves Lower After Mixed Q4 Results, Soft Outlook
- Negative Sentiment: Large crypto flows (e.g., XRP inflows to exchanges) and related risk‑off dynamics can spill into equities and reduce appetite for speculative micro‑caps. XRP Faces $650 Million Sell Risk As US-Iran Conflict Sparks Risk-Off Move
Movano Company Profile
Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.
Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.
Read More
- Five stocks we like better than Movano
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
